Salmeterol xinafoate
CAS No. 94749-08-3
Salmeterol xinafoate ( GR-33343X xinafoate )
产品货号. M16788 CAS No. 94749-08-3
A long-acting beta2-adrenergic receptor agonist (Ki=1.5 nM) used clinically to treat asthma and maintenance of COPD.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥348 | 有现货 |
|
10MG | ¥583 | 有现货 |
|
25MG | ¥1158 | 有现货 |
|
50MG | ¥1936 | 有现货 |
|
100MG | ¥3208 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Salmeterol xinafoate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A long-acting beta2-adrenergic receptor agonist (Ki=1.5 nM) used clinically to treat asthma and maintenance of COPD.
-
产品描述A long-acting beta2-adrenergic receptor agonist (Ki=1.5 nM) used clinically to treat asthma and maintenance of COPD. Asthma Approved
-
同义词GR-33343X xinafoate
-
通路Angiogenesis
-
靶点Adrenergic Receptor
-
受体WTβ2AR
-
研究领域Inflammation/Immunology
-
适应症Asthma
化学信息
-
CAS Number94749-08-3
-
分子量603.75
-
分子式C36H45NO7
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 50 mg/mL
-
SMILESC1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O
-
化学全称2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Isogaya M, et al. Mol Pharmacol. 1998 Oct;54(4):616-22.
2. Hu Z, et al. Cell Mol Immunol. 2012 May;9(3):267-75.
3. Sharma M, et al. J Periodontol. 2017 Mar 3:1-17.
2. Hu Z, et al. Cell Mol Immunol. 2012 May;9(3):267-75.
3. Sharma M, et al. J Periodontol. 2017 Mar 3:1-17.
产品手册
关联产品
-
Carteolol
A non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
-
Oxymetazoline hydroc...
Oxymetazoline Hydrochloride is a selective alpha-1 agonist and partial alpha-2 agonist topical decongestant.Oxymetazoline is a selective alpha-1 agonist and partial alpha-2 agonist topical decongestant used in the form of Oxymetazoline hydrochloride.
-
MK-4618
A potent and selective full β3 adrenergic receptor agonist with EC50 of 1.1 nM; displays no activity for β1 and β2 receptors (EC50>20 uM).